Detalles de la búsqueda
1.
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database.
Ann Rheum Dis
; 81(3): 335-343, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706874
2.
Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy.
RMD Open
; 8(1)2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264432
3.
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial.
Lancet Rheumatol
; 3(2): e122-e130, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279368
Resultados
1 -
3
de 3
1
Próxima >
>>